Stock Earnings

Question 1

What are Sinopharm Group Co. Ltd.'s key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Sinopharm Group Co. Ltd. has a total asset of $392,831, Net profit of $7,049

Question 2

What are the key financial ratios for SHTDY?

Accepted Answer

Sinopharm Group Co. Ltd.'s Current ratio is 1.25, has a Net margin is 1.2, sales per share of $187.3.

Question 3

How is Sinopharm Group Co. Ltd.'s revenue broken down by segment or geography?

Accepted Answer

Sinopharm Group Co. Ltd. largest revenue segment is Pharmaceutical Distribution, at a revenue of 460,322,005,211 in the most earnings release.For geography, China is the primary market for Sinopharm Group Co. Ltd., at a revenue of 633,737,461,156.

Question 4

Is Sinopharm Group Co. Ltd. profitable?

Accepted Answer

yes, according to the latest financial statements, Sinopharm Group Co. Ltd. has a net profit of $7,049

Question 5

Does Sinopharm Group Co. Ltd. have any liabilities?

Accepted Answer

yes, Sinopharm Group Co. Ltd. has liability of 313,947

Question 6

How many outstanding shares for Sinopharm Group Co. Ltd.?

Accepted Answer

Sinopharm Group Co. Ltd. has a total outstanding shares of 3,120.65

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	575,824	584,507	596,569	552,147	521,051	456,414
Revenue Growth (YoY)	-2%	-2%	8%	6%	14%	7%
Cost of Revenue	533,165	540,252	548,057	504,713	477,000	416,091
Gross Profit	42,659	44,255	48,511	47,434	44,050	40,323
Selling, General & Admin	26,144	26,697	27,082	23,790	22,101	20,328
Research & Development	--	--	--	--	--	--
Operating Expenses	25,585	26,484	26,234	24,893	23,207	21,289
Other Non Operating Income (Expenses)	94	-165	-140	-131	-92	-286
Pretax Income	13,614	14,000	19,512	18,563	17,003	15,598
Income Tax Expense	3,752	3,577	4,502	4,218	3,938	3,500
Net Income	6,811	7,049	9,053	8,525	7,758	7,187
Net Income Growth	-21%	-22%	6%	10%	8%	15%
Shares Outstanding (Diluted)	3,120.53	3,120.65	3,120.65	3,120.65	3,120.65	3,111.29
Shares Change (YoY)	0%	0%	0%	0%	0%	5%
EPS (Diluted)	2.18	2.25	2.9	2.73	2.48	2.31
EPS Growth	-21%	-22%	6%	10%	8%	10%
Free Cash Flow	17,094	9,577	14,837	18,546	7,052	9,067
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	7.4%	7.57%	8.13%	8.59%	8.45%	8.83%
Operating Margin	2.96%	3.04%	3.73%	4.08%	3.99%	4.17%
Profit Margin	1.18%	1.2%	1.51%	1.54%	1.48%	1.57%
Free Cash Flow Margin	2.96%	1.63%	2.48%	3.35%	1.35%	1.98%
EBITDA	21,714	19,608	24,077	24,319	22,537	20,645
EBITDA Margin	3.77%	3.35%	4.03%	4.4%	4.32%	4.52%
D&A For EBITDA	4,641	1,838	1,801	1,779	1,695	1,612
EBIT	17,073	17,770	22,276	22,540	20,842	19,033
EBIT Margin	2.96%	3.04%	3.73%	4.08%	3.99%	4.17%
Effective Tax Rate	27.55%	25.55%	23.07%	22.72%	23.16%	22.43%

Sinopharm Group Co. Ltd. (SHTDY) Price

SHTDY Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

EPS (TTM)

Dividend yield

Market Cap

What is Sinopharm Group Co. Ltd.?

SHTDY Income

Follow-Up Questions